Published in Clin Microbiol Infect on July 14, 2009
Sporothrix schenckii and Sporotrichosis. Clin Microbiol Rev (2011) 1.94
Phylogenetic analysis reveals a high prevalence of Sporothrix brasiliensis in feline sporotrichosis outbreaks. PLoS Negl Trop Dis (2013) 1.27
Characterization of virulence profile, protein secretion and immunogenicity of different Sporothrix schenckii sensu stricto isolates compared with S. globosa and S. brasiliensis species. Virulence (2013) 1.19
Emerging sporotrichosis is driven by clonal and recombinant Sporothrix species. Emerg Microbes Infect (2014) 1.06
Sporotrichosis in Rio de Janeiro, Brazil: Sporothrix brasiliensis is associated with atypical clinical presentations. PLoS Negl Trop Dis (2014) 0.99
Phylogeography and evolutionary patterns in Sporothrix spanning more than 14 000 human and animal case reports. Persoonia (2015) 0.95
Chromosomal polymorphism in the Sporothrix schenckii complex. PLoS One (2014) 0.94
Sporotrichosis: an overview and therapeutic options. Dermatol Res Pract (2014) 0.93
Differences in cell morphometry, cell wall topography and gp70 expression correlate with the virulence of Sporothrix brasiliensis clinical isolates. PLoS One (2013) 0.90
Increase in virulence of Sporothrix brasiliensis over five years in a patient with chronic disseminated sporotrichosis. Virulence (2015) 0.87
The difficult management of disseminated Sporothrix brasiliensis in a patient with advanced AIDS. AIDS Res Ther (2015) 0.87
Feline sporotrichosis due to Sporothrix brasiliensis: an emerging animal infection in São Paulo, Brazil. BMC Vet Res (2014) 0.87
Efficacy of posaconazole in murine experimental sporotrichosis. Antimicrob Agents Chemother (2012) 0.86
Sporothrix schenckii Cell Wall Peptidorhamnomannans. Front Microbiol (2011) 0.86
Proteomics-Based Characterization of the Humoral Immune Response in Sporotrichosis: Toward Discovery of Potential Diagnostic and Vaccine Antigens. PLoS Negl Trop Dis (2015) 0.85
What lies beyond genetic diversity in Sporothrix schenckii species complex?: New insights into virulence profiles, immunogenicity and protein secretion in S. schenckii sensu stricto isolates. Virulence (2013) 0.84
Molecular identification of Sporothrix clinical isolates in China. J Zhejiang Univ Sci B (2014) 0.83
Sporotrichosis: an emerging neglected opportunistic infection in HIV-infected patients in Rio de Janeiro, Brazil. PLoS Negl Trop Dis (2014) 0.83
Δ(24)-Sterol Methyltransferase Plays an Important Role in the Growth and Development of Sporothrix schenckii and Sporothrix brasiliensis. Front Microbiol (2016) 0.82
Phenotypic characteristics associated with virulence of clinical isolates from the Sporothrix complex. Biomed Res Int (2015) 0.80
Rapid Identification of Emerging Human-Pathogenic Sporothrix Species with Rolling Circle Amplification. Front Microbiol (2015) 0.80
Sporothrix Species Causing Outbreaks in Animals and Humans Driven by Animal-Animal Transmission. PLoS Pathog (2016) 0.79
Asexual propagation of a virulent clone complex in a human and feline outbreak of sporotrichosis. Eukaryot Cell (2014) 0.79
Draft Genome Sequence of the Dimorphic Fungus Sporothrix pallida, a Nonpathogenic Species Belonging to Sporothrix, a Genus Containing Agents of Human and Feline Sporotrichosis. Genome Announc (2016) 0.79
Molecular epidemiology of human sporotrichosis in Venezuela reveals high frequency of Sporothrix globosa. BMC Infect Dis (2015) 0.79
Minimal inhibitory concentration distributions and epidemiological cutoff values of five antifungal agents against Sporothrix brasiliensis. Mem Inst Oswaldo Cruz (2017) 0.79
Two-dimensional gel electrophoresis data for proteomic profiling of Sporothrix yeast cells. Data Brief (2014) 0.77
Sporothrix schenckiiCOMPLEX:SUSCEPTIBILITIES TO COMBINED ANTIFUNGAL AGENTS AND CHARACTERIZATION OF ENZYMATIC PROFILES. Rev Inst Med Trop Sao Paulo (2015) 0.77
Sporothrix schenckii sensu stricto and Sporothrix brasiliensis Are Differentially Recognized by Human Peripheral Blood Mononuclear Cells. Front Microbiol (2017) 0.76
Acute dacryocystitis: another clinical manifestation of sporotrichosis. Mem Inst Oswaldo Cruz (2014) 0.75
In Vitro and In Vivo Efficacy of Amphotericin B Combined with Posaconazole against Experimental Disseminated Sporotrichosis. Antimicrob Agents Chemother (2015) 0.75
Construction and analysis of the cDNA subtraction library of yeast and mycelial phases of Sporothrix globosa isolated in China: identification of differentially expressed genes. J Zhejiang Univ Sci B (2015) 0.75
Whole-Genome Sequencing and In Silico Analysis of Two Strains of Sporothrix globosa. Genome Biol Evol (2016) 0.75
Atypical Clinical Presentation of Sporotrichosis Caused by Sporothrix globosa Resistant to Itraconazole. Am J Trop Med Hyg (2016) 0.75
Molecular Components of the Sporothrix schenckii Complex that Induce Immune Response. Curr Microbiol (2016) 0.75
Comparison study of broth macrodilution and microdilution antifungal susceptibility tests for the filamentous fungi. Antimicrob Agents Chemother (1996) 5.27
Clinical manifestations, treatment and outcome of Paecilomyces lilacinus infections. Clin Microbiol Infect (2006) 2.67
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol (2008) 2.57
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of mucormycosis 2013. Clin Microbiol Infect (2014) 2.47
Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis (1995) 2.44
Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent? Antimicrob Agents Chemother (2013) 2.14
In vitro activities of four novel triazoles against Scedosporium spp. Antimicrob Agents Chemother (2001) 2.03
Spectrum of zygomycete species identified in clinically significant specimens in the United States. J Clin Microbiol (2009) 2.02
In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother (1997) 2.02
Light- and thermal-induced spin crossover in [Fe(abpt)2(N(CN)2)2]. Synthesis, structure, magnetic properties, and high-spin<-->low spin relaxation studies. Inorg Chem (2001) 2.01
Acremonium species: new emerging fungal opportunists--in vitro antifungal susceptibilities and review. Clin Infect Dis (1997) 1.79
ESCMID and ECMM joint guidelines on diagnosis and management of hyalohyphomycosis: Fusarium spp., Scedosporium spp. and others. Clin Microbiol Infect (2014) 1.70
The single intranigral injection of LPS as a new model for studying the selective effects of inflammatory reactions on dopaminergic system. Neurobiol Dis (2000) 1.70
Emerging pathogens. Med Mycol (2000) 1.59
In vitro activity of voriconazole against dermatophytes, Scopulariopsis brevicaulis and other opportunistic fungi as agents of onychomycosis. Int J Antimicrob Agents (2007) 1.57
Antifungal susceptibilities of Paecilomyces species. Antimicrob Agents Chemother (1998) 1.54
Lipopolysaccharide intranigral injection induces inflammatory reaction and damage in nigrostriatal dopaminergic system. J Neurochem (1998) 1.52
Stress increases vulnerability to inflammation in the rat prefrontal cortex. J Neurosci (2006) 1.50
Effects of incubation temperature, inoculum size, and time of reading on broth microdilution susceptibility test results for amphotericin B fgainst Fusarium. Antimicrob Agents Chemother (1997) 1.49
Mutation rates at Y chromosome specific microsatellites. Hum Mutat (2005) 1.48
Acremonium phylogenetic overview and revision of Gliomastix, Sarocladium, and Trichothecium. Stud Mycol (2011) 1.47
Use of mass spectrometry to identify clinical Fusarium isolates. Clin Microbiol Infect (2009) 1.46
Subcutaneous hyalohyphomycosis caused by Colletotrichum gloeosporioides. J Clin Microbiol (1998) 1.45
A new species of Syspastospora from tropical soils. Mycologia (2010) 1.45
In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother (2001) 1.44
Comments on recent human infections caused by ascomycetes. Med Mycol (1998) 1.43
Psychomotor and intellectual development of children born with intrauterine growth retardation (IUGR). J Pediatr Endocrinol Metab (2004) 1.40
Oral transmission of HIV, reality or fiction? An update. Oral Dis (2006) 1.38
ESCMID and ECMM joint clinical guidelines for the diagnosis and management of systemic phaeohyphomycosis: diseases caused by black fungi. Clin Microbiol Infect (2014) 1.36
Spectrum of clinically relevant Acremonium species in the United States. J Clin Microbiol (2010) 1.35
Molecular characterization, relatedness and antifungal susceptibility of the basidiomycetous Hormographiella species and Coprinus cinereus from clinical and environmental sources. Antonie Van Leeuwenhoek (1996) 1.29
Phaeohyphomycotic cyst caused by Colletotrichum crassipes. J Clin Microbiol (2001) 1.29
Extended method for discrimination of Aeromonas spp. by 16S rDNA RFLP analysis. Int J Syst Evol Microbiol (2000) 1.28
Aquaporins in the central nervous system. Prog Neurobiol (2001) 1.24
Experimental pathogenicity of four opportunist Fusarium species in a murine model. J Med Microbiol (1999) 1.24
Malaria vectors in Bioko Island (Equatorial Guinea): PCR determination of the members of Anopheles gambiae Giles complex (Diptera: Culicidae) and pyrethroid knockdown resistance (kdr) in An. gambiae sensu stricto. J Vector Ecol (2002) 1.23
Isolation and characterization of a new fungal species, Chrysosporium ophiodiicola, from a mycotic granuloma of a black rat snake (Elaphe obsoleta obsoleta). J Clin Microbiol (2008) 1.22
Differential upregulation of aquaporin-4 mRNA expression in reactive astrocytes after brain injury: potential role in brain edema. Neurobiol Dis (1999) 1.21
Comparison of three methods of determining MICs for filamentous fungi using different end point criteria and incubation periods. Antimicrob Agents Chemother (2000) 1.21
Phaeoisaria clematidis as a cause of keratomycosis. J Clin Microbiol (2000) 1.21
Pelvic oxyuriasis. Acta Obstet Gynecol Scand (1986) 1.19
CD40-specific costimulation blockade enhances neonatal porcine islet survival in nonhuman primates. Am J Transplant (2011) 1.19
Distribution of virulence genes in clinical and environmental isolates of Aeromonas spp. Antonie Van Leeuwenhoek (2003) 1.19
Cutaneous infection caused by Aspergillus ustus, an emerging opportunistic fungus in immunosuppressed patients. J Clin Microbiol (2001) 1.18
Comparison of the virulence of Scedosporium prolificans strains from different origins in a murine model. J Med Microbiol (2002) 1.17
Engraftment of adult porcine islet xenografts in diabetic nonhuman primates through targeting of costimulation pathways. Am J Transplant (2007) 1.17
Knockdown resistance mutations (kdr) and insecticide susceptibility to DDT and pyrethroids in Anopheles gambiae from Equatorial Guinea. Trop Med Int Health (2008) 1.17
Novel (60%) and recurrent (40%) androgen receptor gene mutations in a series of 59 patients with a 46,XY disorder of sex development. J Clin Endocrinol Metab (2010) 1.16
In vitro susceptibility to itraconazole, clotrimazole, ketoconazole and terbinafine of 100 isolates of Trichophyton rubrum. Chemotherapy (2001) 1.16
In vitro and in vivo experimental activities of antifungal agents against Fusarium solani. Antimicrob Agents Chemother (1999) 1.16
Type III secretion system genes in clinical Aeromonas isolates. J Clin Microbiol (2004) 1.16
Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole. Antimicrob Agents Chemother (2014) 1.13
Molecular phylogeny and proposal of two new species of the emerging pathogenic fungus Saksenaea. J Clin Microbiol (2010) 1.13
In vitro antifungal activities of the new triazole UR-9825 against clinically important filamentous fungi. Antimicrob Agents Chemother (2001) 1.13
Alternaria infections: laboratory diagnosis and relevant clinical features. Clin Microbiol Infect (2008) 1.11
Mycotic keratitis due to Curvularia senegalensis and in vitro antifungal susceptibilities of Curvularia spp. J Clin Microbiol (1999) 1.11
Bone fracture consolidates faster with low-power laser. Lasers Surg Med (1987) 1.10
Fusarium infections. Criteria for the identification of the responsible species. Mycoses (1993) 1.10
In vitro antifungal susceptibilities of Scopulariopsis isolates. Antimicrob Agents Chemother (1999) 1.08
The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh-TNF-alpha, IL-1beta and IFN-gamma. J Neurochem (2002) 1.07
Diversity of Bipolaris species in clinical samples in the United States and their antifungal susceptibility profiles. J Clin Microbiol (2012) 1.07
Phenotypic identification of Aeromonas genomospecies from clinical and environmental sources. Can J Microbiol (1998) 1.07
High dose intravitreal foscarnet in the treatment of cytomegalovirus retinitis in AIDS. Br J Ophthalmol (1994) 1.06
Phialemonium fungemia: two documented nosocomial cases. J Clin Microbiol (1999) 1.06
Islet xenotransplantation using gal-deficient neonatal donors improves engraftment and function. Am J Transplant (2011) 1.06
Disseminated Scedosporium inflatum infection in a patient with acute myeloblastic leukemia. Eur J Clin Microbiol Infect Dis (1991) 1.05
Detailed localization of aquaporin-4 messenger RNA in the CNS: preferential expression in periventricular organs. Neuroscience (1999) 1.05
Localization of aquaporin-3 mRNA and protein along the gastrointestinal tract of Wistar rats. Pflugers Arch (1999) 1.04
Molecular and phenotypic characterization of Phialemonium and Lecythophora isolates from clinical samples. J Clin Microbiol (2011) 1.03
Clinically relevant Aeromonas species. Clin Infect Dis (2000) 1.02
Mixed infection caused by two species of Fusarium in a human immunodeficiency virus-positive patient. J Clin Microbiol (2000) 1.02
First record of the rare species Aeromonas culicicola from a drinking water supply. Appl Environ Microbiol (2005) 1.02
Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine. Antimicrob Agents Chemother (2012) 1.02
Stress is critical for LPS-induced activation of microglia and damage in the rat hippocampus. Neurobiol Aging (2009) 1.01
Prevalence of Salmonella serotypes in environmental waters and their relationships with indicator organisms. Antonie Van Leeuwenhoek (1999) 1.00
Rapid identification of wine yeast species based on RFLP analysis of the ribosomal internal transcribed spacer (ITS) region. Arch Microbiol (1998) 1.00
Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus: evidence in Parkinson's disease patients. Neurobiol Dis (2010) 0.99
Characterization of Scedosporium prolificans clinical isolates by randomly amplified polymorphic DNA analysis. J Clin Microbiol (1997) 0.98
The X1X2Y sex chromosome system in the fish Hoplias malabaricus. I. G-, C- and chromosome replication banding. Chromosome Res (1997) 0.98
Analysis of ceftriaxone and ceftazidime distribution in cerebrospinal fluid of and cerebral extracellular space in awake rats by in vivo microdialysis. Antimicrob Agents Chemother (1995) 0.97
Ferromagnetic Coupling through Spin Polarization in a Dinuclear Copper(II) Metallacyclophane. Angew Chem Int Ed Engl (2001) 0.97
Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method. Antimicrob Agents Chemother (2013) 0.96
Neurological impairment in alpha-mannosidosis: a longitudinal clinical and MRI study of a brother and sister. Childs Nerv Syst (1999) 0.96
Characterisation of Aeromonas spp. isolated from frozen fish intended for human consumption in Mexico. Int J Food Microbiol (2003) 0.96